Medicamen Organics Limited (NSE:MEDIORG)
India · Delayed Price · Currency is INR 24.30
0.00 (0.00%)
Aug 19, 2026, 3:26 PM IST
Medicamen Organics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -40.19 | 40.47 | 26.24 | 9.69 | 1.01 |
Depreciation & Amortization | 6.2 | 5.97 | 7.19 | 7.12 | 6.8 |
Other Operating Activities | -7 | 17.08 | 12.18 | 1.63 | 4.08 |
Change in Accounts Receivable | 72.28 | -91.52 | -59.32 | -45.23 | 12.84 |
Change in Inventory | -30.28 | -13.47 | -0.04 | -14.17 | -20.61 |
Change in Accounts Payable | -61.77 | 46.23 | -19.19 | 24.81 | 4.81 |
Change in Other Net Operating Assets | 14.82 | -50.2 | -3.69 | 10.32 | -8.56 |
Operating Cash Flow | -45.95 | -45.43 | -36.62 | -5.84 | 0.37 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -17.38 | -24.47 | -3.51 | -2.89 | -6.16 |
Other Investing Activities | 0.22 | 0.95 | 0.13 | 0.08 | 0.23 |
Investing Cash Flow | -17.16 | -23.53 | -3.37 | -2.81 | -5.93 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 10.52 | - | 12.54 | - | - |
Long-Term Debt Issued | 8.88 | - | - | 15.49 | 6.56 |
Total Debt Issued | 19.4 | - | 12.54 | 15.49 | 6.56 |
Short-Term Debt Repaid | - | -3 | - | - | - |
Long-Term Debt Repaid | - | -0.04 | -3.93 | - | - |
Total Debt Repaid | - | -3.03 | -3.93 | - | - |
Net Debt Issued (Repaid) | 19.4 | -3.03 | 8.62 | 15.49 | 6.56 |
Issuance of Common Stock | 30 | 105.4 | 38 | - | - |
Other Financing Activities | -14.56 | 2.36 | -6.47 | -6.12 | -4.73 |
Financing Cash Flow | 34.84 | 104.73 | 40.14 | 9.37 | 1.83 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | -0 | -0 | - | - |
Net Cash Flow | -28.27 | 35.77 | 0.15 | 0.72 | -3.73 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -63.34 | -69.9 | -40.13 | -8.73 | -5.79 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -27.99% | -18.30% | -15.88% | -3.94% | -2.76% |
Free Cash Flow Per Share | -5.37 | -6.32 | -5.31 | -1.46 | -0.96 |
Levered Free Cash Flow | -51.77 | -72.1 | -52.37 | -20.54 | -10.79 |
Unlevered Free Cash Flow | -47.33 | -69.11 | -48.47 | -17.01 | -8.07 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 7.06 | 5.14 | 6.47 | 5.66 | 4.36 |
Cash Income Tax Paid | 1.25 | 0.94 | 1.81 | 0.48 | 0.65 |
Change in Working Capital | -4.95 | -108.95 | -82.23 | -24.27 | -11.52 |